The trial concluded March 25, and with FDA approval already secured, the device is expected to reach the general market soon after. With its participation, Memorial Healthcare System continues its ...

Pleural effusion was independently linked to increased all-cause mortality in US veterans with CHF, cancer, and pneumonia.

Neurally adjusted ventilatory assist (NAVA) offers superior patient-ventilator synchrony in paediatric liver transplant ...